Viome Life Sciences’s $67M Extension Round Is A Good Sign For Diagnostics
When the Biden Administration began sending out at-home COVID-19 testing kits, the vision was to keep a stock of easy-to-use diagnostic tools in the medicine cabinet alongside bandages and bottles of pain relief drugs. That led to a slew of startups entering the little-known diagnostics world .
Read More from the Global Wellness News ™